[ET Net News Agency, 12 May 2026] INNOGEN-B (02591) fell 9.3% to HK$15.14.
It hits an intra-day low of HK$15, and an intra-day high of HK$16.55. The total shares traded was 2.1 million, with a value of HK$32.68m. The active buy/sell ratio is 39:61, with net selling turnover of HK$5.99m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$1.62m, with volume weighted average price of HK$15.474. BNP PARIBAS SEC (ASIA) accounts for greatest net responsive selling turnover of HK$1.59m, with volume weighted average price of HK$15.276.
Basic Information| Nominal | 15.140 | % Chg | -9.34% |
| High | 16.550 | Low | 15.000 |
| Shares Tr | 2.1m | Turnover | 32.68m |
| 10-D SMA | 14.408 | %H.V | 132.650 |
| 20-D SMA | 16.612 | VWAP | 15.562 |
| 50-D SMA | 20.130 | RSI14 | 42.035 |
Status: Active buy/sell ratio is 39:61, with net selling turnover of HK$5.99m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOGEN-B (02591) | 15.14 | -9.34 |
| GENSCRIPT BIO (01548) | 14.62 | -4.32 |
| INNOVENT BIO (01801) | 88.30 | +0.06 |
| XTALPI (02228) | 9.09 | -0.98 |
| WUXI XDC (02268) | 54.60 | -0.36 |
| WUXI BIO (02269) | 33.22 | +0.48 |
| BAO PHARMA-B (02659) | 27.52 | -0.86 |
| BEONE MEDICINES (06160) | 188.80 | -0.89 |
| ZAI LAB (09688) | 15.67 | +3.57 |
| AKESO (09926) | 132.60 | +0.99 |
(ed)
Nominal 
